"Therapeutic adherence is defined as “the extent to which a person’s behaviour – taking medication, following a diet, and/or executing lifestyle change - corresponds with agreed recommendations from a health care provider”. It is estimated that each year the poor adherence to medical treatments in Europe causes about 200,000 deaths and burdens on health expenditure up to 80 billion euro a year (AIFA source).
TRILLIO wants to improve health of Europeans citizens by increasing therapeutic adherence in elderly people and in patient affected by chronic diseases.
TRILLIO is a therapeutic adherence device really similar to an “alarm clock”, thus really familiar for elderly. The TRILLIO device is provided with an app that optimizes the connections among various players and organizations who share a common goal: make sure a patient follows his or her pharmaceutical treatment plan. At the centre of this ecosystem is the user, often a senior, surrounded by various stakeholders, all of whom play a key role in the patient's well-being, i.e. family members and caregivers. When it's time to take a drug, TRILLIO alerts the user with a sound and a visual alarm, while showing all the relevant information on its 2.7"" e-paper display. If the user doesn't press the button on the device to turn off the alarm within ten minutes, TRILLIO automatically sends a notification to any family member connected to the system. TRILLIO has been already tested in Italy and received several endorsement and letter of intents by organisations in Italy and abroad.
We are a targeting and overall population composed by 150.000.000 European that are suffering from Chronic diseases, 50% of them have difficulties in following a therapy.
TRILLIO wants to contribute in easing the communication among all the actors of patients ecosystem, enclosing, the patients itself, the family members and the caregivers. The expected output is to contribute to the improvement of adherence to medical plans and medication at European level.
"
